Nutrient-Sensitive Senescence Checkpoints in Diabetic Kidney Disease

Abstract

Diabetic kidney disease (DKD) remains a leading cause of chronic kidney disease and kidney failure despite advances in glucose-lowering, hemodynamic, anti-inflammatory, and cardiorenal protective therapies. Cellular senescence has emerged as a key cell fate pathway linking persistent diabetic stress to renal inflammation, fibrosis, impaired repair, and progressive nephron loss. However, senescence in DKD should not be viewed simply as a terminal response to hyperglycemia, oxidative stress, or DNA damage. In this article, we define nutrient-sensitive senescence checkpoints as metabolic decision nodes that integrate amino acid flux, mitochondrial quality control, lipid routing, redox balance, oxygen stress, endoplasmic reticulum (ER) proteostasis, and inflammatory danger signaling to determine renal cell fate. We distinguish classical senescence in proliferative renal cells from senescence-like dysfunction in postmitotic podocytes, and we emphasize that interpretation requires a composite phenotype rather than any single marker. We discuss how serine, branched chain amino acids, arginine-citrulline metabolism, tryptophan-derived metabolites, and carnitine-linked lipid handling shape cell fate pathways in podocytes, tubular epithelial cells, endothelial cells, and immune-stromal compartments. We further examine how mitophagy, ferroptotic lipid peroxidation, ER stress, mitochondrial DNA leakage, cGAS-STING activation, AMPK-mTOR signaling, NAD+-sirtuin pathways, and nuclear receptor networks convert nutrient stress into maladaptive renal aging. Finally, we outline therapeutic opportunities to reprogram nutrient-sensitive senescence, including established DKD therapies, mitochondrial quality control enhancement, lipid-routing correction, senolytics, senomorphics, hypoxia-inducible factor pathway modulation, and biomarker-guided precision medicine. Article Highlights Diabetic kidney disease remains progressive in many patients despite modern cardiorenal therapies, suggesting that additional persistent cell fate pathways sustain kidney injury. An unresolved question is how nutrient-derived signals determine whether renal cells undergo adaptive repair or maladaptive senescence-like dysfunction. Amino acid flux, mitophagy, lipid routing, redox balance, endoplasmic reticulum proteostasis, and inflammatory danger signaling may form nutrient-sensitive senescence checkpoints in diabetic kidney disease. Distinguishing cell cycle arrest in proliferative cells from composite senescence-like injury in postmitotic cells may improve biomarker-based patient stratification and guide metabolism-informed senescence-targeted therapies.